I'm sure Supertramp meant biotech startups. Obviously any established biotech companies generating sales and profits like CSL and Cochlear will be valued based on their financial performance as well as market expectation of future performance.
Told you so!! IMU heading to $200m Mkt Cap, page-48
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.001(0.93%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.3¢ | $404.4K | 7.439M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 3790463 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 961418 | 17 |
View Market Depth
| Last trade - 12.40pm 30/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |